Collaborative Care Model for Perinatal Depression Support Services – Population-Level Upstream Systems Change (COMPASS-PLUS): A Hybrid Type 2 Cluster Randomized Trial
- Institution
- WOMEN AND INFANTS HOSPITAL-RHODE ISLAND, RI
- Principal investigator
- Emily Stinnett Miller
- Funding
- $744K
- Duration
- 2023–2028
Moonbase score
Still being scored
Abstract
Over 15% of women in the United States are impacted by depression during or after pregnancy. Untreated perinatal depression dramatically impairs maternal quality of life and, in its most extreme form, can lead to suicide which remains a leading contributor to maternal mortality. Despite recognition of its importance, multiple barriers exist in the depression care cascade. One of these barriers is the existing health system structure, wherein obstetric and psychiatric care exists in silos and non-medical contributors to health are not integrated into care plans. Without a synergistic approach to the whole woman, both physically and mentally, screening for depressive symptoms occurs inconsistently. Even when screening occurs and depression is diagnosed, treatment is often not initiated, depressive symptoms are not tracked, and care is not escalated with the goal of symptom remission. This lack in coordinated and personalized care has left thousands of women vulnerable each year in the United States. Moreover, there are significant differences in perinatal depression care which contribute to the widening racial and ethnic differences in quality of life, maternal morbidity, and maternal mortality. It is imperative that we identify alternative mechanisms to adequately identify and treat perinatal depression and incorporate mental healthcare as a component of interventions designed to reduce maternal mortality and severe maternal morbidity. The collaborative care model (CCM), when implemented in the primary care context, leads to improvements in mental health outcomes. However, the perinatal context is unique on the patient, clinician, and systems levels. Thus the perinatal CCM (pCCM) requires its own validation. One small (n=168), randomized trial suggests the pCCM is efficacious in reducing depressive symptoms. Despite these data, pCCM remains rarely utilized due to two existing gaps in the research-to-practice continuum. First, the existing efficacy data lack generalizability needed for broad dissemination. Second, no studies have been published to inform best practices with respect to an implementation strategies package for pCCM, with attention to the unique aspects of the perinatal context. Moreover, the persistent differences observed across populations in pregnancy outcomes and perinatal mental health require an intentional and innovative approach that builds upon the traditional CCM foundations and centers identification and mitigation of non-medical contributors to health. We will leverage existing clinical algorithms and databases developed for an established and successful pCCM to perform a rigorous stepped-wedge cluster-randomized trial to evaluate the effect of an enhanced pCCM [COMPASS-PLUS (Collaborative Care Model for Perinatal Depression Support Services – Population-Level Upstream Systems Change)] on maternal mental health outcomes. We will optimize an implementation strategy package tailored to perinatal care via a hybrid type 2 implementation-effectiveness design with the goal of broad dissemination of the pCCM.
Research team
- Emily FeinbergPI
- Emily Stinnett MillerPI
LOADING MOONBASE SCORE
Questions for WOMEN AND INFANTS HOSPITAL-RHODE ISLAND
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Brown UniversityNot yet scored
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
Emily Feinberg · $626K · 2022–2025
- NIH · Women and Infants Hospital-Rhode Island42
Neuroprotective Strategy: Novel Purine Derivatives for Neonatal Hypoxia-ischemia
Xiaodi Felix Chen · $444K · 2021–2027
- NIH · Women and Infants Hospital-Rhode IslandNot yet scored
Requirement for Ubiquitin C-Terminal Hydrolase function in mammalian ovarian health and fertility
Kathryn J Grive · $408K · 2024–2029